You are here
- Home
Total number of clinical trials
- collapse A Phase I, Open-label, Multiple-dose, Dose-escalation Study To Assess the Safety, Tolerability and Pharmacokinetics of AZD8931 in Patients with Advanced Solid Malignancies
- collapse A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
- collapse PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated patients Assesment of the correlation between Body Mass Index and recurrence among Zoladex treated prostate cancer patients
- collapse A Double-blind Placebo-controlled, Randomised, Single centre, First Time in Man Study to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Inhaled Doses of AZD7624 in Healthy Subjects
- collapse A Randomised, Double-Blind, 2-Period Crossover Study to Assess the Effect of Steady-State AZD6140 on the Pharmacokinetics of a Single Oral 500-mg Dose of Tolbutamide, a Substrate of CYP2C9, in Healthy Male and Female Volunteers.
- collapse A Phase I/II Multi-centre Study of AZD8931 in Combination with Weekly Paclitaxel to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced Solid Tumours and in a Selected Population with Low HER2-expressing Locally Recurrent and/or Metastatic Breast Cancer (THYME)
- collapse A Phase 1, Single Centre, Double-blind, Randomised, Placebo-controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics after Administration of Multiple Ascending (MAD) Once Weekly Inhaled Doses of AZD8848 in Healthy Subjects
- collapse A Multicentre, Retrospective Chart Review Study to Characterise Gefitinib Usage and Outcomes in Routine Treatment
- collapse A Phase I, Randomized, DoubleBlind Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Inhaled Doses (MAD) of AZD7624 to Healthy Subjects and Patients with COPD
- collapse A Phase I, Open-Label, Multi-centre Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of AZD8330 in Patients With Advanced Malignancies
